Living-Donor Lobar Lung Transplantation for Pulmonary Arterial Hypertension After Failure of Epoprostenol Therapy

Journal of the American College of Cardiology

Volumn 50, Issue 6, 2007, Pages 523-527

  Date, Hiroshi ^a   Kusano, Kengo Fukushima ^a   Matsubara, Hiromi ^a   Ogawa, Aiko ^a   Fujio, Hideki ^a   Miyaji, Katsumasa ^a   Okazaki, Megumi ^a   Yamane, Masaomi ^a   Toyooka, Shinichi ^a   Aoe, Motoi ^a   Sano, Yoshifumi ^a   Hanazaki, Motohiko ^a   Goto, Keiji ^a   Kasahara, Shingo ^a   Sano, Shunji ^a   Ohe, Tohru ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; ENDOTHELIN RECEPTOR ANTAGONIST; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; PROSTANOID;

ADOLESCENT; ADULT; ARTERY RECONSTRUCTION; ARTICLE; BRONCHIOLITIS OBLITERANS; CADAVER DONOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CRITICAL ILLNESS; DISEASE COURSE; FEMALE; FOLLOW UP; GRAFT FAILURE; HEMOPTYSIS; HUMAN; LIVING DONOR; LUNG ARTERY PRESSURE; LUNG EDEMA; LUNG LOBE; LUNG TRANSPLANTATION; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; REOPERATION; SCHOOL CHILD; SURVIVAL; SURVIVAL RATE; THORACOTOMY; TREATMENT FAILURE;

ADOLESCENT; ADULT; ANTIHYPERTENSIVE AGENTS; CHILD; EPOPROSTENOL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LIVING DONORS; LUNG TRANSPLANTATION; MALE; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; TREATMENT FAILURE;

EID: 34547156130     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.03.054     Document Type: Article

References (15)

1. Simonneau G., Galie N., Rubin L.J., et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43 Suppl 12 (2004) 5S-12S
2. Sitbon O., Humbert M., Nunes H., et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 40 (2002) 780-788
3. McLaughlin V.V., Shillington A., and Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 106 (2002) 1477-1482
4. Kuhn K.P., Byrne D.W., Arbogast P.G., Doyle T.P., Loyd J.E., and Robbins I.M. Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol. Am J Respir Crit Care Med 167 (2003) 580-586
5. Yung D., Widlitz A.C., Rosenzweig E.B., Kerstein D., Maislin G., and Barst R.J. Outcomes in children with idiopathic pulmonary arterial hypertension. Circulation 110 (2004) 660-665
6. Trulock E.P., Edwards L.B., Taylor D.O., Boucek M.M., Keck B.M., and Hertz M.I. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report-2005. J Heart Lung Transplant 24 (2005) 956-967
7. Starnes V.A., Bowdish M.E., Woo M.S., et al. A decade of living donor lobar lung transplantation: recipient outcomes. J Thorac Cardiovasc Surg 127 (2004) 114-122
8. Date H., Aoe M., Sano Y., et al. Improved survival after living-donor lobar lung transplantation. J Thorac Cardiovasc Surg 128 (2004) 933-940
9. Rich S., Dantzker D.R., Ayres S.M., et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 107 (1987) 216-223
10. Trulock E.P. Recipient selection. Chest Surg Clin North Am 3 (1993) 1-12
11. Date H., Aoe M., Nagahiro I., et al. Living-donor lobar lung transplantation for various lung diseases. J Thorac Cardiovasc Surg 126 (2003) 476-481
12. Date H., Sano Y., Aoe M., et al. Living-donor single lobe lung transplantation for primary pulmonary hypertension in a child. J Thorac Cardiovasc Surg 123 (2002) 1211-1213
13. Rubin L.J., Badesch D.B., Barst R.J., et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346 (2002) 896-903
14. Galiè N., Ghofrani H.A., Torbicki A., et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353 (2005) 2148-2157
15. Date H., Nagahiro I., Aoe M., et al. Living-donor lobar lung transplantation for primary pulmonary hypertension in an adult. J Thorac Cardiovasc Surg 122 (2001) 817-818